CFDB - Cystic Fibrosis DataBase

ongoing trials trial from

Standardizing Treatments for Pulmonary Exacerbations - Aminoglycoside Study - Phase 4 - Not yet recruiting

Study design (if review, criteria of inclusion for studies)

Interventional - Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment


Cystic Fibrosis|Cystic Fibrosis Pulmonary Exacerbation - 6 Years and older   (Child, Adult, Older Adult)


Drug: Beta-lactam antibiotic|Drug: Aminoglycoside

Outcome measures

Absolute Change in FEV1 % Predicted at Week 4 in Aminoglycoside (AG) Study|Incidence of Adverse Events (AEs) in Aminoglycoside (AG) Study Intervention Arms|Absolute Change in CFRSD-CRISS Score at Week 4 in Aminoglycoside (AG) Study

Keywords: Adolescent; Adult; Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; Drug Administration Schedule; Infection; Netilmicin; pharmacological_intervention; Pneumonia; Pseudomonas aeruginosa; Pseudomonas; Respiratory Tract Diseases; Respiratory Tract Infections; Tobramycin; Exacerbation;